World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
25972
World Ranking
11020
National Ranking
5671

Overview

Sunil Krishnan is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research spans multiple disciplines including Engineering, Health Professions, and Medicine, with specific emphasis on Biomedical Engineering, Organic Chemistry, Emergency Medical Services, Geriatrics and Gerontology, and Health Information Management.

Their recent publications cover a range of topics primarily centered on advanced sensor technology, patient safety, and gene therapy. These include works such as:

  • Advances in real-time water quality monitoring using triboelectric nanosensors, 2025, Journal of Materials Chemistry A
  • Connecting the Dots: Communication's Role in Reducing Medication Errors - A Systematic Review, 2025, Sarvodaya International Journal of Medicine
  • 169 First-in-human safety and mechanism of action (MOA) analyses of repeatedly dosed in vivo gene delivery for directed human type III collagen (COL3) expression in aesthetics, 2021, Journal of Investigative Dermatology

Their work addresses topics including Advanced Sensor and Energy Harvesting Materials, Advanced Chemical Sensor Technologies, Polydiacetylene-based materials and applications, Patient Safety and Medication Errors, Pharmaceutical Practices and Patient Outcomes, Electronic Health Records Systems, and Virus-based gene therapy research.

The most frequent publication venues for their work are:

  • Journal of Materials Chemistry A
  • Sarvodaya International Journal of Medicine
  • Journal of Investigative Dermatology

Sunil Krishnan has collaborated with several co-authors, including Adewale Giwa, B. Ramesh, Pooja Singh, N. Angeloff, and N. Reitze, reflecting a multidisciplinary approach spanning materials science, medical research, and clinical communication.

Best Publications

  • Curcumin Potentiates Antitumor Activity of Gemcitabine in an Orthotopic Model of Pancreatic Cancer through Suppression of Proliferation, Angiogenesis, and Inhibition of Nuclear Factor-κB–Regulated Gene Products

    Ajaikumar B. Kunnumakkara;Sushovan Guha;Sunil Krishnan;Parmeswaran Diagaradjane

  • PDL1 Regulation by p53 via miR-34

    Maria Angelica Abdalla Cortez;Cristina Ivan;David Valdecanas;Xiaohong Wang

  • Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma

    Matthew Harold Katz;Matthew Harold Katz;Huamin Wang;Jason B Fleming;Charlotte C Sun

  • Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head

    Gauri R. Varadhachary;Robert A. Wolff;Christopher H. Crane;Charlotte C. Sun

  • Neoadjuvant Treatment Response As an Early Response Indicator for Patients With Rectal Cancer

    In Ja Park;Y. Nancy You;Atin Agarwal;John M. Skibber

  • Nanoparticle-mediated hyperthermia in cancer therapy

    Dev Kumar Chatterjee;Parmeswaran Diagaradjane;Sunil Krishnan

  • Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?

    Michael B. Bernstein;Sunil Krishnan;James W. Hodge;Joe Y. Chang

  • Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer.

    Prajnan Das;John M. Skibber;Miguel A. Rodriguez-Bigas;Barry W. Feig

  • Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation of Smad4(Dpc4) Immunostaining With Pattern of Disease Progression

    Christopher H. Crane;Gauri R. Varadhachary;John S. Yordy;Gregg A. Staerkel

  • Biliary cancer: Utility of next-generation sequencing for clinical management.

    Milind Javle;Tanios Bekaii-Saab;Apurva Jain;Ying Wang

  • Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy

    Sunil Krishnan;Vishal Rana;Nora A. Janjan;Gauri R. Varadhachary

  • Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation

    Sunil Krishnan;Awalpreet S. Chadha;Yelin Suh;Hsiang Chun Chen

  • Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?

    Chad Tang;Xiaohong Wang;Hendrick Soh;Steven Seyedin

  • Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177

    Paul D. Brown;Sunil Krishnan;Jann N. Sarkaria;Wenting Wu

  • The dosimetric feasibility of gold nanoparticle-aided radiation therapy (GNRT) via brachytherapy using low-energy gamma-/x-ray sources

    Sang Hyun Cho;Bernard L Jones;Sunil Krishnan

  • Modulation of in vivo tumor radiation response via gold nanoshell-mediated vascular-focused hyperthermia: characterizing an integrated antihypoxic and localized vascular disrupting targeting strategy.

    Parmeswaran Diagaradjane;Anil Shetty;James C. Wang;Andrew M. Elliott

  • Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis

    Randa Tao;Sunil Krishnan;Priya R. Bhosale;Milind M. Javle

  • Gold nanoparticles in breast cancer treatment: Promise and potential pitfalls

    Jihyoun Lee;Jihyoun Lee;Dev Kumar Chatterjee;Min Hyuk Lee;Sunil Krishnan

  • Estimation of microscopic dose enhancement factor around gold nanoparticles by Monte Carlo calculations

    Bernard L. Jones;Sunil Krishnan;Sang Hyun Cho

  • Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer

    Kuzhuvelil B. Harikumar;Ajaikumar B. Kunnumakkara;Gautam Sethi;Parmeswaran Diagaradjane

Frequent Co-Authors

Christopher H. Crane
Christopher H. Crane Memorial Sloan Kettering Cancer Center
Robert A. Wolff
Robert A. Wolff The University of Texas MD Anderson Cancer Center
Bruce D. Minsky
Bruce D. Minsky The University of Texas MD Anderson Cancer Center
Cathy Eng
Cathy Eng Vanderbilt University
John M. Skibber
John M. Skibber The University of Texas MD Anderson Cancer Center
George J. Chang
George J. Chang The University of Texas MD Anderson Cancer Center
Miguel A. Rodriguez-Bigas
Miguel A. Rodriguez-Bigas The University of Texas MD Anderson Cancer Center
Milind Javle
Milind Javle The University of Texas MD Anderson Cancer Center
Barry W. Feig
Barry W. Feig The University of Texas MD Anderson Cancer Center
Jaffer A. Ajani
Jaffer A. Ajani The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean following a traditional path. Online programs now offer greater flexibility and open doors to various roles in healthcare. For those interested in healthcare administration, best mha programs can help you develop critical management skills to lead hospitals or health systems.

Existing nurses looking to advance their training while balancing work can consider rn to bsn online no clinicals accredited options, which enable career growth without the need for additional on-site clinical experience.

Doctor of Nursing Practice (DNP) degrees have also become more accessible online. Students who need an accelerated path can look into the dnp programs online or pursue specialized 1 year dnp program online tracks.

Each of these online degree options is designed to fit busy lifestyles and fast-track your advancement in the healthcare industry. Explore the programs that align best with your career ambitions.

Best Scientists Citing Sunil Krishnan

Trending Scientists

Recently Published Articles